Drug Importer Pleads Guilty To Selling Misbranded Drugs

ALEXANDRIA, Va. - A Virginia-based drug importer and its co-owner on Dec. 2 pleaded guilty to federal criminal charges related to the importation of misbranded Botox, chemotherapy drugs and other drugs, the U.S. Attorney's Office for the Eastern District of Virginia said in a press release (United States of America v. Gallant Pharma International Inc., et al., No. 13-cr-130, E.D. Va., Alexandria Div.).

Access this news story on lexis.com®